Canada's share of scientific publications in the top 10% of cited works in drug discovery is forecasted to show a consistent slight increase from 2024 to 2028, growing from 12.57% in 2024 to 12.61% in 2028. Considering that the data from 2023 shows an actual standing at 12.56%, this represents a minimal year-on-year increase over the period. The projected CAGR over these five years suggests a stable annual growth trend.

Future trends to watch for include:

The impact of potential policy changes or funding increases in Canada's scientific research sector, which could influence publication impact.
Technological advancements in drug discovery methodologies, which might alter the landscape of Canadian contributions in global research.
Collaborations and partnerships among Canadian institutions and international entities, potentially affecting citation metrics.